PTC — PTC Inc.

Sentiment as of 2026-09-13 is genuinely split. The tape is bearish: PTC was down 7.26% in the week and 11.63% in the month into 2026-09-13, sits 11.23% below its 20-day and 11.57% below its 200-day average, and has an RSI of 35.9. The bear case rests on optics — Q3 FY26 GAAP revenue of $600.0M was down ~6.8% year-over-year versus the $643.9M reported in the June 2025 quarter — plus a soft industrial capex backdrop and a wave of price-target trims (Stifel cut to $165 from $180, Citigroup to $141). The sell-side, however, stayed constructive: the rating breakdown is 20 Buy / 10 Hold / 3 Sell with a $162.71 consensus target and a $153.71 recent average, and management actually raised full-year constant-currency ARR growth guidance to ~9.25% and lifted revenue and non-GAAP EPS expectations on July 29, 2026. The market is trading the headline revenue decline; the sell-side is trading the ARR and cash-flow improvement. That gap is the whole story.

The three-year trend is best described as optically deteriorating, fundamentally stable-to-improving. Reported revenue is lumpy and currently falling: Q1 FY26 $685.8M (+21.4% YoY), Q2 FY26 $774.3M (+21.7% YoY), then Q3 FY26 $600.0M (-6.8% YoY versus Q3 FY25's $643.9M). That Q1/Q2 strength followed by a sharp Q3 decline is not demand destruction — it reflects the completed divestitures of Kepware and ThingWorx, which removed low-margin revenue from the consolidated base, and it is why headline GAAP revenue is misleading. The metric that matters — constant-currency ARR — grew 9.1% ex-divestitures to $2.448B with $60M of net new ARR in the quarter. Free cash flow is unambiguously trending up: TTM FCF through 2026-06-30 is $935.4M versus $856.7M for the TTM ending 2025-09-30, roughly +9% YoY, with Q3 FY26 FCF of $249.3M against $242.0M a year earlier. Margins are choppier than the trailing figures suggest: operating margin was 27.7% in Q3 FY26 versus 32.6% in Q3 FY25 (a genuine year-over-year compression worth watching), but 38.2% in Q2 FY26 versus 35.1%, and 32.2% in Q1 FY26 versus 20.4%. Net income is heavily distorted — Q2 FY26 booked $590.7M of net income and $4.99 diluted EPS versus $162.6M and $1.35 in Q2 FY25, a one-off gain (consistent with the divestiture proceeds) that inflates TTM EPS to $10.67 and makes the 12.6x trailing P/E meaningless. Verdict: the revenue decline is a portfolio artifact, ARR and FCF are compounding at roughly 9%, but Q3 FY26 operating-margin compression means the 'divestitures lift margins' thesis has not yet shown up cleanly in the data.

Cheap on cash flow, fair-to-cheap on earnings, and cheap versus its own history — but not a giveaway relative to its growth rate. As of 2026-09-13 at $130.78: the 12.6x TTM P/E and 0.088 PEG are both artifacts of the $590.7M one-off gain in Q2 FY26 and should be ignored. The honest numbers are ~16.0x forward non-GAAP EPS ($130.78 / $8.19 FY26E, with guidance of $7.87–$8.42), 5.11x trailing P/S against a 5-year average of 8.08x, 9.7x EV/EBITDA, and a ~6.2% trailing FCF yield ($935.4M TTM FCF on a $15.1B market cap). The deterministic overlay scores valuation context at 97.9 — 'Cheap vs. its own history' — and the data supports it: 5.11x sales versus an 8.08x five-year average is a ~37% discount, and the 45.54x five-year average P/E (itself GAAP-distorted) is nowhere in sight. The caveat is that a chunk of that historical premium was a zero-rate artifact, and 16x forward earnings for ~9% ARR growth is a fair, not heroic, multiple in a derated software market. Net: modestly undervalued, with the discount defensible rather than extreme.

At $130.78 as of 2026-09-13, the stock is pricing a business that is shrinking — roughly 16x forward non-GAAP EPS for a company with 84.1% gross margins, ~9% constant-currency ARR growth, 37.8% trailing operating margin, and a buyback program running at $1.625B for FY26 against a $15.1B market cap (over 10% of the float annually). That multiple only makes sense if you believe ARR growth decelerates toward mid-single digits, or that software multiples keep compressing. The re-rating trigger is concrete: if the November 11, 2026 Q4 FY26 print delivers the ARR step-up and initial FY27 guidance holds near ~9%, the multiple should migrate toward the high-teens/low-20s, which is where the sell-side sits ($153.71 recent average target, $162.71 consensus). The failure mode is equally concrete: net new ARR slipping below the ~$60M/quarter pace would turn the low P/E into a classic value trap as FY27 estimates get cut. This is an estimate-revision story, not a multiple-expansion story — watch net new ARR, not revenue.

Weak, but approaching the zone where oversold bounces begin. As of 2026-09-13: RSI(14) 35.93, price 11.23% below its 20-day average (that implies a 20-day near $147.32), 5.01% below its 50-day (implies ~$137.68) and 11.57% below its 200-day (implies ~$147.89). The stock returned -7.26% in a week, -11.63% in a month, but +15.04% over three months and -16.11% over six — so a June–July rally has been fully given back. Price sits in the lower third of a $108.50–$208.56 52-week range. Entry-timing implication: this is not a confirmed base. RSI below 40 with price under all three moving averages argues against chasing, but with the 20-day and 200-day clustered at roughly $147–148 and the 50-day at ~$137.68, those are the levels to watch — a reclaim of ~$137.68 followed by ~$147 would be the first real evidence that the downtrend is over. Until then, the path of least resistance is still down.

• Industrial and discrete-manufacturing capex caution: elevated borrowing costs and cautious enterprise budgets across automotive, aerospace and defense have compressed software multiples sector-wide and lengthened PTC's sales cycles.
• Enterprise AI spending dynamics: manufacturers must clean up product data foundations ('systems of record') before deploying AI, which is a structural tailwind for PTC's PLM/CAD franchises — but AI-native design tooling is simultaneously a credible long-term competitive threat to incumbent CAD/PLM vendors.
• Persistent software-sector multiple derating: PTC's five-year average P/E of 45.54 and P/S of 8.08 reflect the zero-rate era; the current ~16x forward earnings and 5.11x sales show how far the sector's valuation regime has reset, and there is no guarantee it snaps back.
• Currency and constant-currency reporting: management guides on constant-currency ARR, and FX swings can create gaps between reported and underlying performance that muddy quarter-to-quarter comparisons.
• Tariffs, trade policy and global industrial production: PTC's end markets are global and cyclical, so trade friction or an industrial recession hits net new ARR with a lag.
• Interest rates and debt-funded capital returns: rising long-term debt (from $1.173B at 2026-03-31 to $1.398B at 2026-06-30) makes the buyback partly rate-sensitive.

• Q4 and full-year FY26 earnings on November 11, 2026 (after market close): the single most important event — Q4 ARR step-up, deferred ARR health for FY27, and initial FY2027 guidance metrics.
• Continued share repurchase execution: $525M bought back in Q3 FY26 alone, FY26 target ~$1.625B, diluted share count expected at ~116M — every dollar spent below intrinsic value is a direct per-share EPS tailwind.
• AI product monetization: the nearly seven-figure ServiceMax AI deal (largest AI contract to date), Creo AI and PTC Orbit rollouts translating into incremental net new ARR.
• Potential further portfolio rationalization or M&A using divestiture proceeds, which would keep the GAAP revenue decline narrative in the headlines.
• An industrial capex recovery or rate-cut cycle that revives manufacturing software budgets and re-rates the whole group.

• GAAP revenue contraction is now the headline: Q3 FY26 revenue fell ~6.8% year-over-year, and the next-FY revenue estimate of $2.723B implies continued decline versus TTM revenue of $2.954B — if investors anchor on revenue rather than ARR, the multiple can compress further regardless of business quality.
• Net new ARR deceleration: the ~$60M quarterly pace and ~9% constant-currency growth could slip to mid-single digits if industrial macro stays soft, which would turn 'cheap' into a value trap.
• Balance-sheet creep from debt-funded buybacks: long-term debt rose to $1.398B and total liabilities to $3.044B at 2026-06-30, with a thin current ratio of 1.025 and D/E up from 0.40 to 0.46 in one quarter; capital returns are increasingly levered.
• Margin durability: Q3 FY26 operating margin compressed year-over-year to 27.7% from 32.6%, undercutting the thesis that divesting lower-margin assets mechanically lifts profitability.
• Competitive pressure from larger industrial software platforms (Siemens, Dassault, Autodesk) bundling suites and from AI-native design tools that could commoditize PTC's core CAD/PLM interfaces.
• One-off distortion risk: the $590.7M Q2 FY26 net income quarter means TTM EPS ($10.67) and the 12.6x P/E are misleading, and any investor screening on those figures is mispricing the stock in both directions.

This is a reasonably attractive risk/reward for a patient investor, but not a compelling one right now. You are buying a sticky, 84%-gross-margin industrial software franchise growing ARR ~9%, generating ~$935M of trailing free cash flow (a ~6.2% yield), and retiring more than 10% of its market cap annually in buybacks, for ~16x forward non-GAAP EPS — a meaningful discount to its own five-year history (5.11x sales versus 8.08x) and to software peers. What you are not getting is a clean entry: GAAP revenue is shrinking, operating margin compressed year-over-year in the most recent quarter, leverage is creeping up to fund the buyback, and the tape (RSI 35.9, price below all three major moving averages on 2026-09-13) shows no sign of a base. I would characterize this as accumulate-on-weakness rather than buy-the-breakout — the November 11 Q4 FY26 ARR print is the real decision point.

Independent blended valuation as of 2026-09-13: 60% weight on a forward P/E of 19.5x applied to the $8.19 FY26E non-GAAP EPS estimate (PTC's own guidance range is $7.87–$8.42), which nets $159.71, and 40% weight on a 6.0% forward free-cash-flow yield applied to estimated FY27 FCF of ~$1.0B and ~112M shares post-buyback (~$8.93 FCF/share), which nets ~$148; the blended result rounds to $158. The 19.5x multiple is deliberately between the ~16.0x the stock trades at and the 25x+ the business commanded pre-derating, justified by 84.1% gross margins, ~9% constant-currency ARR growth, a 37.8% trailing operating margin and a buyback running above 10% of market cap annually, while the 6.0% FCF yield reflects the same conclusion from the cash-flow side — two independent methods converging within ~7%.